RayKnowChina Research Map
Shortlist0

GuangzhouGuangzhou Medical University

Guangzhou Women and Children's Medical Center

广州市妇女儿童医疗中心

Listed for 24 of the 53 diseases this site covers, from the research papers it led and the trials registered with it as lead sponsor or site.

Research activity in public records, not a rating of care. Whether the hospital can help a particular patient is for the hospital and the treating doctor to say.

No official website checked for this hospital yet.

Getting in touch

Research at Guangzhou Women and Children's Medical Center

Choose a disease to see the papers and trials behind it. Each tile shows papers led, 2021–2025, and papers per year.

Only the 53 diseases this site covers. A disease it is not listed for means this hospital did not meet the listing rule for that disease in these records; it does not mean the hospital does not treat it. Which hospitals are listed

  1. Nasopharyngeal carcinoma鼻咽癌2 papers led
  2. Hepatoblastoma肝母细胞瘤9 papers led
  3. Retinoblastoma视网膜母细胞瘤3 papers led
  4. Osteosarcoma骨肉瘤1 paper led
  5. Gastrointestinal stromal tumour胃肠道间质瘤0 papers led
  6. Neuroblastoma神经母细胞瘤32 papers led1 open trial led
  7. B-cell acute lymphoblastic leukaemiaB 细胞急性淋巴细胞白血病2 papers led1 open trial led
  8. Beta thalassaemiaβ 地中海贫血19 papers led1 open trial led
  9. Haemophilia A血友病 A0 papers led
  10. Neuromyelitis optica spectrum disorder视神经脊髓炎谱系疾病1 paper led
  11. Wilson disease肝豆状核变性(Wilson 病)2 papers led
  12. Biliary atresia胆道闭锁19 papers led
  13. Anti-NMDA receptor encephalitis抗 NMDA 受体脑炎3 papers led
  14. Idiopathic pulmonary fibrosis特发性肺纤维化1 paper led
  15. Amyotrophic lateral sclerosis肌萎缩侧索硬化症0 papers led
  16. Pompe disease庞贝病1 paper led
  17. Duchenne muscular dystrophy杜氏肌营养不良2 papers led
  18. Alport syndromeAlport 综合征2 papers led
  19. IgA nephropathyIgA 肾病0 papers led
  20. Gaucher disease戈谢病1 paper led
  21. Osteogenesis imperfecta成骨不全症1 paper led
  22. Primary sclerosing cholangitis原发性硬化性胆管炎0 papers led
  23. Congenital diaphragmatic hernia先天性膈疝11 papers led
  24. Hirschsprung disease先天性巨结肠7 papers led

Not listed for: Oesophageal squamous cell carcinoma, Hepatocellular carcinoma, Stomach cancer, Chordoma, Ewing sarcoma, Multiple myeloma, Aplastic anaemia, Haemophagocytic lymphohistiocytosis, Atypical haemolytic uraemic syndrome, Thrombotic thrombocytopenic purpura, Fanconi anaemia, IgG4-related disease, Myasthenia gravis, Moyamoya disease, Takayasu arteritis, Hepatic echinococcosis, Lymphangioleiomyomatosis, Spinal muscular atrophy, Fabry disease, Behçet disease, Niemann–Pick disease type C, Primary biliary cholangitis, Inherited epidermolysis bullosa, Hereditary angioedema, Familial adenomatous polyposis, Leber hereditary optic neuropathy, Majeed syndrome, NGLY1 deficiency, ISG15 deficiency.

Cancer

Nasopharyngeal carcinoma

鼻咽癌

Led 2 of the 2,375 English-language PubMed papers on nasopharyngeal carcinoma with an author in mainland China, 2021–2025: 0.08%.

Papers led
2
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 1120212022: 0020222023: 1120232024: 0020242025: 002025

23 hospitals in Guangzhou for nasopharyngeal carcinoma176 hospitals in China for nasopharyngeal carcinoma

No open trial on nasopharyngeal carcinoma lists this hospital on ClinicalTrials.gov on 8 Nov 2026.

The records behind these numbers
ThemesRadiotherapy techniqueImaging & AIRecurrent / metastatic disease
Departments in papersRadiology / nuclear medicine

Run the PubMed searchClinicalTrials.gov

Cancer

Hepatoblastoma

肝母细胞瘤

Led 9 of the 154 English-language PubMed papers on hepatoblastoma with an author in mainland China, 2021–2025: 5.8%.

Papers led
9
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 3320212022: 1120222023: 1120232024: 1120242025: 332025

8 hospitals in Guangzhou for hepatoblastoma88 hospitals in China for hepatoblastoma

No open trial on hepatoblastoma lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersPediatricsPathology / laboratory medicineMedical oncology
Papers it led9
  1. Association of the YTHDF2 rs3738067 A>G variant with hepatoblastoma risk: a multicenter case-control study in Chinese children.2025BMC cancer
  2. Association of the pri-miR-34b/c rs4938723 T > C polymorphism with hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study.2025BMC medical genomics
  3. nNOS-mediated S-nitrosylation of TCOF1 regulates KRAS proteostasis to suppress hepatoblastoma progression.2025Redox biology
  4. IMPDH2 Positively Impacts the Proliferation Potential of Hepatoblastoma Cells by Activating JunB Signaling Pathway.2024Current molecular pharmacology
  5. TRMT61B rs4563180 G>C variant reduces hepatoblastoma risk: a case-control study of seven medical centers.2023Aging
  6. METTL14 gene polymorphisms influence hepatoblastoma predisposition in Chinese children: Evidences from a seven-center case-control study.2022Gene
  7. Polymorphisms in METTL3 gene and hepatoblastoma risk in Chinese children: A seven-center case-control study.2021Gene
  8. Genetic variations in nucleotide excision repair pathway genes and hepatoblastoma susceptibility.2021International journal of cancer
  9. Association between lncRNA-H19 polymorphisms and hepatoblastoma risk in an ethic Chinese population.2021Journal of cellular and molecular medicine
Earlier papers (2016–2020)5
  1. Outcomes of children with hepatoblastoma who underwent liver resection at a tertiary hospital in China: a retrospective analysis.2020BMC pediatrics
  2. Liver biopsy for hepatoblastoma: a single institution's experience.2020Pediatric surgery international
  3. YTHDC1 gene polymorphisms and hepatoblastoma susceptibility in Chinese children: A seven-center case-control study.2020The journal of gene medicine
  4. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.2020The journal of gene medicine
  5. Microwave ablation combined with transcatheter arterial chemoembolization is effective for treating unresectable hepatoblastoma in infants and children.2018Medicine

Run the PubMed searchClinicalTrials.gov

Cancer

Retinoblastoma

视网膜母细胞瘤

Led 3 of the 301 English-language PubMed papers on retinoblastoma with an author in mainland China, 2021–2025: 1.0%.

Papers led
3
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 1120212022: 1120222023: 0020232024: 0020242025: 112025

8 hospitals in Guangzhou for retinoblastoma196 hospitals in China for retinoblastoma

No open trial on retinoblastoma lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersRadiology / nuclear medicine

Run the PubMed searchClinicalTrials.gov

Cancer

Osteosarcoma

骨肉瘤

Led 1 of the 2,257 English-language PubMed papers on osteosarcoma with an author in mainland China, 2021–2025: 0.04%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 1120222023: 0020232024: 0020242025: 002025

33 hospitals in Guangzhou for osteosarcoma742 hospitals in China for osteosarcoma

No open trial on osteosarcoma lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersPediatrics
Papers it led1
  1. The role of m6A modification in pediatric cancer.2022Biochimica et biophysica acta. Reviews on cancer
Earlier papers (2016–2020)2
  1. Different formins restrict localization of distinct tropomyosins on dorsal stress fibers in osteosarcoma cells.2020Cytoskeleton (Hoboken, N.J.)
  2. LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients.2017Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Run the PubMed searchClinicalTrials.gov

Cancer

Gastrointestinal stromal tumour

胃肠道间质瘤

Led no English-language PubMed papers on gastrointestinal stromal tumour in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

13 hospitals in Guangzhou for gastrointestinal stromal tumour261 hospitals in China for gastrointestinal stromal tumour

No open trial on gastrointestinal stromal tumour lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Run the PubMed searchClinicalTrials.gov

Cancer

Neuroblastoma

神经母细胞瘤

Led 32 of the 1,132 English-language PubMed papers on neuroblastoma with an author in mainland China, 2021–2025: 2.8%.

Papers led
32
2021–2025
Trials led
1
any status, ClinicalTrials.gov
Open trials led
1
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 4420212022: 4420222023: 8820232024: 1120242025: 15152025

23 hospitals in Guangzhou for neuroblastoma352 hospitals in China for neuroblastoma

Open trials with this hospital 1

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 13 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma
    Phase
    Not given
    Started
    2024-05
    Registry
    NCT06574698

    Age 1 year to 21 years (registered criteria)

    Led by Guangzhou Women and Children's Medical CenterGuangzhou

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers
Departments in papersPediatricsPathology / laboratory medicine
Papers it led32
  1. Association between MYCN gene polymorphisms and neuroblastoma susceptibility: a case-control study in Chinese children from Jiangsu Province.2025BMC cancer
  2. m1A methylase TRMT6 promotes neuroblastoma development by demethylating SST mRNA in an m1A/YTHDF2-dependent manner.2025British journal of cancer
  3. Degradation of IRF6 by TRIM59 in tumor cells triggers PGM1-mediated glycolysis to regulate cell proliferation in neuroblastoma.2025Cell death & disease
  4. Associations of CCAT2 gene polymorphisms with neuroblastoma susceptibility in children from Jiangsu province.2025European journal of medical research
  5. Association of MALAT1 gene polymorphisms with neuroblastoma susceptibility in children from Jiangsu Province.2025Human genomics
  6. Genetic variants of m1A modification genes and the risk of neuroblastoma: novel insights from a Chinese case-control study.2025Human genomics
  7. YTHDF3 rs7464 A > G polymorphism increases Chinese neuroblastoma risk: A multiple-center case-control study.2025IUBMB life
  8. Association of TRDMT1 Gene Polymorphisms With Neuroblastoma Susceptibility: Insights From a Case-Control Study.2025Journal of cellular and molecular medicine
  9. EDF1 accelerates ganglioside GD3 accumulation to boost CD52-mediated CD8+ T cell dysfunction in neuroblastoma.2025Journal of experimental & clinical cancer research : CR
  10. Identification of IFI27 involvement in the progression of neuroblastoma through bioinformatics analysis and experimental assays.2025Journal of molecular histology
  11. Increased risk of neuroblastoma in Chinese children from Jiangsu province with NSUN4 gene rs10736428 A>C polymorphism.2025Journal of neurosurgery. Pediatrics
  12. The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma.2025Neuro-oncology
  13. Leptin decreases Th17/Treg ratio to facilitate neuroblastoma via inhibiting long-chain fatty acid catabolism in tumor cells.2025Oncoimmunology
  14. Neuroblastoma susceptibility and association of N7-methylguanosine modification gene polymorphisms: multi-center case-control study.2025Pediatric research
  15. RAS gene polymorphisms confer the risk of neuroblastoma in Chinese children from Jiangsu province.2025Pediatric surgery international
  16. Functional TET2 gene polymorphisms increase the risk of neuroblastoma in Chinese children.2024IUBMB life
  17. Comprehensive exploration of the involvement of cuproptosis in tumorigenesis and progression of neuroblastoma.2023BMC genomics
  18. MIR938 rs2505901 T>C polymorphism is associated with increased neuroblastoma risk in Chinese children.2023Bioscience reports
  19. miR-100 rs1834306 a > G polymorphism decreases neuroblastoma risk in Chinese children.2023Cancer reports (Hoboken, N.J.)
  20. NSUN2 gene rs13181449 C>T polymorphism reduces neuroblastoma risk.2023Gene
  21. Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma.2023Journal for immunotherapy of cancer
  22. Functional polymorphisms of the TET1 gene increase the risk of neuroblastoma in Chinese children.2023Journal of cellular and molecular medicine
  23. Association between GPC2 polymorphisms and neuroblastoma risk in Chinese children.2023Journal of clinical laboratory analysis
  24. Iron overload facilitates neonatal hypoxic-ischemic brain damage via SLC7A11-mediated ferroptosis.2023Journal of neuroscience research
  25. SNHG25 facilitates SNORA50C accumulation to stabilize HDAC1 in neuroblastoma cells.2022Cell death & disease
  26. Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology.2022Frontiers in immunology
  27. circ0125803 facilitates tumor progression by sponging miR-197-5p and upregulating E2F1 in neuroblastoma.2022Pathology, research and practice
  28. Targeting RAS in neuroblastoma: Is it possible?2022Pharmacology & therapeutics
  29. MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma.2021Cell death & disease
  30. FABP4 deactivates NF-κB-IL1α pathway by ubiquitinating ATPB in tumor-associated macrophages and promotes neuroblastoma progression.2021Clinical and translational medicine
  31. Curcumin induced G2/M cycle arrest in SK-N-SH neuroblastoma cells through the ROS-mediated p53 signaling pathway.2021Journal of food biochemistry
  32. hsa_circ_0013401 Accelerates the Growth and Metastasis and Prevents Apoptosis and Autophagy of Neuroblastoma Cells by Sponging miR-195 to Release PAK2.2021Oxidative medicine and cellular longevity
Earlier papers (2016–2020)29
  1. Correlation between the genetic variants of base excision repair (BER) pathway genes and neuroblastoma susceptibility in eastern Chinese children.2020Cancer communications (London, England)
  2. lncRNA-uc003opf.1 rs11752942 A>G polymorphism decreases neuroblastoma risk in Chinese children.2020Cell cycle (Georgetown, Tex.)
  3. LIN28A gene polymorphisms modify neuroblastoma susceptibility: A four-centre case-control study.2020Journal of cellular and molecular medicine
  4. Association of MYC gene polymorphisms with neuroblastoma risk in Chinese children: A four-center case-control study.2020The journal of gene medicine
  5. [Cervical giant neuroblastoma in an infant: a case report].2020Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  6. Pleiotropic effect of common PHOX2B variants in Hirschsprung disease and neuroblastoma.2019Aging
  7. Nodal increases the malignancy of childhood neuroblastoma cells via regulation of Zeb1.2019BioFactors (Oxford, England)
  8. Targeting β3-adrenergic receptor signaling inhibits neuroblastoma cell growth via suppressing the mTOR pathway.2019Biochemical and biophysical research communications
  9. Associations between H19 polymorphisms and neuroblastoma risk in Chinese children.2019Bioscience reports
  10. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.2019Journal of experimental & clinical cancer research : CR
  11. Impact of extent of resection on survival in high-risk neuroblastoma: A systematic review and meta-analysis.2019Journal of pediatric surgery
  12. Heat shock protein 70 as a supplementary receptor facilitates enterovirus 71 infections in vitro.2019Microbial pathogenesis
  13. APEX1 Polymorphisms and Neuroblastoma Risk in Chinese Children: A Three-Center Case-Control Study.2019Oxidative medicine and cellular longevity
  14. Associations between lncRNA MEG3 polymorphisms and neuroblastoma risk in Chinese children.2018Aging
  15. The rs2147578 C > G polymorphism in the Inc-LAMC2-1:1 gene is associated with increased neuroblastoma risk in the Henan children.2018BMC cancer
  16. Lack of associations between AURKA gene polymorphisms and neuroblastoma susceptibility in Chinese children.2018Bioscience reports
  17. LINC00673 rs11655237 C>T confers neuroblastoma susceptibility in Chinese population.2018Bioscience reports
  18. HOTAIR gene polymorphisms contribute to increased neuroblastoma susceptibility in Chinese children.2018Cancer
  19. Functional Polymorphisms at ERCC1/XPF Genes Confer Neuroblastoma Risk in Chinese Children.2018EBioMedicine
  20. RSRC1 and CPZ gene polymorphisms with neuroblastoma susceptibility in Chinese children.2018Gene
  21. MiR-181a/b induce the growth, invasion, and metastasis of neuroblastoma cells through targeting ABI1.2018Molecular carcinogenesis
  22. The TP53 gene rs1042522 C>G polymorphism and neuroblastoma risk in Chinese children.2017Aging
  23. Recombinant heat shock protein 78 enhances enterovirus 71 propagation in Vero cells and is induced in SK-N-SH cells during the infection.2017Archives of virology
  24. Surgical management and outcomes of ganglioneuroma and ganglioneuroblastoma-intermixed.2017Pediatric surgery international
  25. The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population.2016International journal of medical sciences
  26. Potentially functional polymorphisms in the LIN28B gene contribute to neuroblastoma susceptibility in Chinese children.2016Journal of cellular and molecular medicine
  27. Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese population.2016Journal of cellular and molecular medicine
  28. LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population.2016Oncotarget
  29. Evaluation of GWAS-identified SNPs at 6p22 with neuroblastoma susceptibility in a Chinese population.2016Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
All its trials on ClinicalTrials.gov, any status1
  1. Adding Of Naxitamb In Induction Therapy For High Risk NeuroblastomaRecruitingNCT06574698Lead sponsorStart 2024-05

Run the PubMed searchClinicalTrials.gov

Blood disorders

B-cell acute lymphoblastic leukaemia

B 细胞急性淋巴细胞白血病

Led 2 of the 225 English-language PubMed papers on B-cell acute lymphoblastic leukaemia with an author in mainland China, 2021–2025: 0.9%.

Papers led
2
2021–2025
Trials led
1
any status, ClinicalTrials.gov
Open trials led
1
recruiting or about to
Open trials as a site
4
led by another institution
Papers led per year
2021: 2220212022: 0020222023: 0020232024: 0020242025: 002025

8 hospitals in Guangzhou for B-cell acute lymphoblastic leukaemia90 hospitals in China for B-cell acute lymphoblastic leukaemia

Open trials with this hospital 5

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 8 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
    Phase
    Phase 1
    Started
    2024-10
    Registry
    NCT06752785

    Age 1 year to 18 years (registered criteria)

    Led by Guangzhou Women and Children's Medical CenterGuangzhou

  2. Recruiting
    Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
    Phase
    Phase 2/Phase 3
    Started
    2025-01
    Registry
    NCT06764238

    Age 1 month to 18 years (registered criteria)

    Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC; 24 listed hospitals as study sitesChangsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hefei, Jinan, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Shenzhen, Suzhou, Tianjin, Wuhan, Xi'an

  3. Recruiting
    Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
    Phase
    Phase 2/Phase 3
    Started
    2025-03
    Registry
    NCT06882057

    Age 1 year to 18 years (registered criteria)

    Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC; 23 listed hospitals as study sitesChangsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hefei, Jinan, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Suzhou, Tianjin, Wuhan, Xi'an

  4. Recruiting
    Newly-diagnosed Pediatric Ph-positive B-ALL Protocol
    Phase
    Phase 3
    Started
    2025-03
    Registry
    NCT07152041

    Age 1 month to 18 years (registered criteria)

    Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC; 20 listed hospitals as study sitesChangsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Jinan, Nanchang, Nanjing, Qingdao, Shanghai, Shenzhen, Suzhou, Tianjin, Wuhan

  5. Recruiting
    A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
    Phase
    Phase 1/Phase 2
    Started
    2023-02
    Registry
    NCT05667506

    Age 3 years to 18 years (registered criteria)

    Lead sponsor is not a listed hospital; 9 listed hospitals as study sitesChongqing, Guangzhou, Hefei, Nanchang, Nanjing, Tianjin, Wuhan, Xuzhou

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers
ThemesMRD & relapseChildren
Departments in papersMedical oncology

Run the PubMed searchClinicalTrials.gov

Blood disorders

Beta thalassaemia

β 地中海贫血

Led 19 of the 312 English-language PubMed papers on beta thalassaemia with an author in mainland China, 2021–2025: 6.1%.

Papers led
19
2021–2025
Trials led
1
any status, ClinicalTrials.gov
Open trials led
1
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 4420212022: 7720222023: 4420232024: 1120242025: 332025

23 hospitals in Guangzhou for beta thalassaemia157 hospitals in China for beta thalassaemia

Open trials with this hospital 1

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 13 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia
    Phase
    N/A
    Started
    2024-10
    Registry
    NCT06734520

    Age 7 years to 10 years (registered criteria)

    Led by Guangzhou Women and Children's Medical CenterGuangzhou

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers
Papers it led19
  1. Lowering cyclosporine trough concentration threshold effectively mitigates acute graft-versus-host disease in children with severe β-Thalassemia post hematopoietic stem cell transplantation.2025European journal of clinical pharmacology
  2. Prevalence and Molecular Characteristics of Hemoglobin Variants in Laibin City, Central Guangxi of Southern China.2025Hemoglobin
  3. Risk-Stratified Pretransplant Immunosuppressive Strategy Improves Outcomes of Unrelated Cord Blood Transplantation in Pediatric β-Thalassemia Major.2025Transplantation and cellular therapy
  4. A 6-Year Follow-up of a Chinese Child with Homozygous β0-Thalaasemia and a Heterozygous KLF1 Mutation.2024Hemoglobin
  5. Application of real-time PCR-based multicolor melting curve with automatic analysis system in pregestational and prenatal thalassemia diagnoses.2023Annals of human genetics
  6. High accuracy of single-molecule real-time sequencing in detecting a rare α-globin fusion gene in carrier screening population.2023Annals of human genetics
  7. β-Thalassemia Trait Caused by SUPT5H Defects: Another Case Report.2023Hemoglobin
  8. Gut microbiota trajectory in β-thalassemia major children who underwent allogeneic hematopoietic stem cell transplantation.2023Transplant infectious disease : an official journal of the Transplantation Society
  9. Impaired bone marrow microenvironment and stem cells in transfusion-dependent beta-thalassemia.2022Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  10. Detection of rare thalassemia mutations using long-read single-molecule real-time sequencing.2022Gene
  11. Identification of a Novel Mutation in the 3' Untranslated Region of the β-Globin Gene (HBB:c.*132C>G) in a Chinese Family.2022Hemoglobin
  12. β-Thalassemia Intermedia Caused by the β-Globin Gene 3' Untranslated Region: Another Case Report.2022Hemoglobin
  13. Dominantly Inherited β-Thalassemia Caused by a Single Nucleotide Deletion in Exon 3 of the β-Globin Gene: Hb Xiangyang (HBB: c.393delT).2022Hemoglobin
  14. Dysregulated Serum Cytokine Production in Pediatric Patients with β-Thalassemia Major.2022Hemoglobin
  15. Using affected embryos to establish linkage phase in preimplantation genetic testing for thalassemia.2022Reproductive biology and endocrinology : RB&E
  16. Improved Non-Invasive Preimplantation Genetic Testing for Beta-Thalassemia Using Spent Embryo Culture Medium Containing Blastocoelic Fluid.2021Frontiers in endocrinology
  17. Noninvasive prenatal testing of α-thalassemia and β-thalassemia through population-based parental haplotyping.2021Genome medicine
  18. Dominant β-Thalassemia Phenotype Caused by Hb Dieppe (HBB: c.383A>G): Another Case Report.2021Hemoglobin
  19. Hb Lepore-Hong Kong: First Report of a Novel δ/β-Globin Gene Fusion in a Chinese Family.2021Hemoglobin
Chinese-language papers (not in the count)1
  1. [Molecular Epidemiological Characteristics and Differential Diagnosis of Common δβ-Thalassemia/HPFH].2022Zhongguo shi yan xue ye xue za zhi
Earlier papers (2016–2020)24
  1. Molecular epidemiology and hematologic characterization of δβ-thalassemia and hereditary persistence of fetal hemoglobin in 125,661 families of greater Guangzhou area, the metropolis of southern China.2020BMC medical genetics
  2. The Trend in Timing of Prenatal Diagnosis for Thalassemia at a Chinese Tertiary Obstetric Center.2020Hemoglobin
  3. Hematological Characteristics of β-Globin Gene Mutation -50 (G>A) (HBB: c.-100G>A) Carriers in Mainland China.2020Hemoglobin
  4. [Research advances in transplantation for thalassemia major].2020Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
  5. A β-Thalassemia Trait with Two Mutations in Cis in a Chinese Family.2019Hemoglobin
  6. Coinheritance of Hb City of Hope (HBB: c.208G>A) and β-Thalassemia: Compromising the Molecular Diagnosis of the Codons 71/72 (+A) (HBB: c.216_217insA) Mutation by Reverse Dot-Blot Hybridization.2019Hemoglobin
  7. A Krüppel-Like Factor 1 Gene Mutation Ameliorates the Severity of β-Thalassemia: A Case Report.2019Hemoglobin
  8. Regulatory Single Nucleotide Polymorphism rs368698783 (G>A): a Genetic Modifier of Hb F Production Only under Erythropoietic Stress Characteristic for β-Globin Chain Deficiency?2019Hemoglobin
  9. α-Haemoglobin pool measurement: a useful biomarker for evaluation of β-thalassaemia intermedia?2018British journal of haematology
  10. Results of Coexistence of β-Thalassemia Minor in Hb H Disease Patients.2018Hemoglobin
  11. Analysis of the Genotypes in a Chinese Population with Increased Hb A2 and Low Hematological Indices.2018Hemoglobin
  12. δ-Thalassemia with Complete Absence of Hb A2 in a Chinese Family.2018Hemoglobin
  13. A KLF1 gene mutation causes β-thalassemia minor in a Chinese family.2018International journal of laboratory hematology
  14. Invasive prenatal diagnosis of fetal thalassemia.2017Best practice & research. Clinical obstetrics & gynaecology
  15. Hb Hornchurch [β43(CD2)Glu→Lys; HBB: c.130G>A] Compromises the Molecular Diagnosis of β-Thalassemia in a Chinese Family.2017Hemoglobin
  16. Hb A2-Tianhe (HBD: c.323G>A): First Report in a Chinese Family with Normal Hb A2-β-Thalassemia Trait.2017Hemoglobin
  17. First Report of the Rare IVS-II-705 (T>G) β-Thalassemia Mutation in a Chinese Family.2017Hemoglobin
  18. A Novel Frameshift Mutation at Codons 138/139 (HBB: c.417_418insT) on the β-Globin Gene Leads to β-Thalassemia.2017Hemoglobin
  19. Combination of Hb Heze [β144(HC1)Lys→Arg; HBB: c.434A>G] and β0-Thalassemia in a Chinese Patient with β-Thalassemia Intermedia.2017Hemoglobin
  20. Characterization of a novel β-globin gene cluster deletion causing (A γδβ)0 -thalassemia by next-generation sequencing.2017International journal of laboratory hematology
  21. Diagnosis and treatment of neoplastic post-transplant lymphoproliferative disorder following hematopoietic stem cell transplant in β-thalassemia: A pediatric case report.2017Medicine
  22. A New δ-Globin Gene Variant: Hb A2-Fengshun [δ121(GH4)Glu→Lys (HBD: c.364G > A)].2016Hemoglobin
  23. Consequences of Delayed Prenatal Diagnosis of β-Thalassemia in Mainland China.2016Hemoglobin
  24. Up-regulation of NKG2A inhibitory receptor on circulating NK cells contributes to transfusion-induced immunodepression in patients with β-thalassemia major.2016Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban
All its trials on ClinicalTrials.gov, any status2
  1. Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemiaRecruitingNCT06734520Lead sponsorN/AStart 2024-10
  2. A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-ThalassaemiaTerminatedNCT04925206Study sitePhase 1Start 2021-08

Run the PubMed searchClinicalTrials.gov

Blood disorders

Haemophilia A

血友病 A

Led no English-language PubMed papers on haemophilia A in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

8 hospitals in Guangzhou for haemophilia A160 hospitals in China for haemophilia A

No open trial on haemophilia A lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Run the PubMed searchClinicalTrials.gov

Other diseases

Neuromyelitis optica spectrum disorder

视神经脊髓炎谱系疾病

Led 1 of the 485 English-language PubMed papers on neuromyelitis optica spectrum disorder with an author in mainland China, 2021–2025: 0.2%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
1
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 1120232024: 0020242025: 002025

9 hospitals in Guangzhou for neuromyelitis optica spectrum disorder67 hospitals in China for neuromyelitis optica spectrum disorder

Open trials with this hospital 1

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 8 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
    Phase
    Phase 3
    Started
    2026-05
    Registry
    NCT05199688

    Age 2 years to 11 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteGuangzhou

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers
ThemesBiologic drugsAcute attack treatmentAntibodies & diagnosis
Departments in papersNeurology

Run the PubMed searchClinicalTrials.gov

Other diseases

Wilson disease

肝豆状核变性(Wilson 病)

Led 2 of the 201 English-language PubMed papers on Wilson disease with an author in mainland China, 2021–2025: 1.0%.

Papers led
2
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 1120222023: 0020232024: 1120242025: 002025

5 hospitals in Guangzhou for Wilson disease28 hospitals in China for Wilson disease

No open trial on Wilson disease lists this hospital on ClinicalTrials.gov on 8 Nov 2026.

The records behind these numbers
ThemesGenetics (ATP7B)Diagnosis & copper testsChildren
Papers it led2
  1. Clinical characteristics and prognosis of early diagnosed Wilson's disease: A large cohort study.2024Liver international : official journal of the International Association for the Study of the Liver
  2. Assessment of the diagnostic value of serum ceruloplasmin for Wilson's disease in children.2022BMC gastroenterologyFree full text
Chinese-language papers (not in the count)1
  1. [Phenotypes and ATP7B gene variants in 316 children with Wilson disease].2022Zhonghua er ke za zhi = Chinese journal of pediatrics

Run the PubMed searchClinicalTrials.gov

Other diseases

Biliary atresia

胆道闭锁

Led 19 of the 214 English-language PubMed papers on biliary atresia with an author in mainland China, 2021–2025: 8.9%.

Papers led
19
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 2220212022: 5520222023: 3320232024: 4420242025: 442025

2 hospitals in Guangzhou for biliary atresia28 hospitals in China for biliary atresia

No open trial on biliary atresia lists this hospital on ClinicalTrials.gov on 8 Nov 2026.

The records behind these numbers
ThemesScreening & diagnosisDisease mechanisms
Departments in papersPediatricsRadiology / nuclear medicine
Papers it led19
  1. A dysregulated hepcidin-iron axis impairs antiviral immunity and induces lethal liver pathology in neonates.2026Immunity
  2. Dual Functions and Therapeutic Potential of FZD6 in Biliary Atresia.2025Digestive diseases and sciences
  3. Identification of Biliary Atresia in Infantile Cholestasis: Integrating Radiomics With MRCP for Unobservable Extrahepatic Biliary Systems.2025Journal of computer assisted tomography
  4. Early differential diagnosis of cystic biliary atresia and choledochal cyst in the fetus: A multicenter retrospective study.2025Journal of hepato-biliary-pancreatic sciences
  5. Comprehensive images and serum biomarkers for biliary atresia and other cholestasis in pediatrics.2025Scientific dataFree full text
  6. Alterations of gut microbiota in infants with biliary atresia identified by 16S rRNA-sequencing.2024BMC pediatricsFree full text
  7. MAPK signaling pathway induced LOX-1+ polymorphonuclear myeloid-derived suppressor cells in biliary atresia.2024Clinical immunology (Orlando, Fla.)
  8. Key postnatal magnetic resonance characteristics for differentiating cystic biliary atresia from choledochal cyst.2024European radiology
  9. Proteomics Defines Plasma Biomarkers for the Early Diagnosis of Biliary Atresia.2024Journal of proteome researchFree full text
  10. MiR-100 rs1834306 A>G Increases Biliary Atresia Risk in Southern Han Chinese Children.2023BioMed research internationalFree full text
  11. A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia.2023Journal of visualized experiments : JoVE
  12. The association of immune-related genes and the potential role of IL10 with biliary atresia.2023Pediatric research
  13. Latest diagnostic performance of different ultrasonic features for biliary atresia.2022Acta radiologica (Stockholm, Sweden : 1987)
  14. A model incorporating serum C3 complement levels may be useful for diagnosing biliary atresia in infants.2022Gastroenterologia y hepatologia
  15. Accuracy of Magnetic Resonance Imaging in Prenatal Diagnosis of Choledochal Cysts: A Single-Center Retrospective Analysis.2022International journal of clinical practiceFree full text
  16. Peripheral blood CD177+ cells as an early diagnostic marker for biliary atresia: A prospective multicentre study in pediatric patients with cholestasis.2022Journal of hepatology
  17. CD177+ cells produce neutrophil extracellular traps that promote biliary atresia.2022Journal of hepatology
  18. Association of miRNA-492 rs2289030 G>C and miRNA-938 rs2505901 T>C Gene Polymorphisms with Biliary Atresia Susceptibility.2021Biomedical and environmental sciences : BES
  19. Down-regulation of STAT3 enhanced chemokine expression and neutrophil recruitment in biliary atresia.2021Clinical science (London, England : 1979)Free full text
All its trials on ClinicalTrials.gov, any status4
  1. Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomyTerminatedNCT06121375Study sitePhase 2/Phase 3Start 2024-09
  2. An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary AtresiaActive, not recruitingNCT05426733Study sitePhase 3Start 2022-07
  3. Evaluation of Maralixibat in Biliary Atresia Response Post-KasaiCompletedNCT04524390Study sitePhase 2Start 2021-07
  4. Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)CompletedNCT04336722Study sitePhase 3Start 2020-07
More papers found outside PubMed (not counted)4
  1. A Novel Real-Time Deep Learning Screening for Prenatal and Neonatal Biliary Atresia Diagnosis for Ghost Gallbladders: Better Interpretation and More Novice-Friendly2025SSRN Electronic Journalpreprint
  2. Folic acid prevents interferon-induced iron accumulation and ferroptosis and improves liver health in children with biliary atresia2023medRxivpreprint
  3. JoVE Video Dataset2023Venue not listeddataset
  4. A model incorporating serum C3 complement levels may be useful for diagnosing biliary atresia in infants2022Gastroenterología y Hepatología (English Edition)article

Run the PubMed searchClinicalTrials.gov

Other diseases

Anti-NMDA receptor encephalitis

抗 NMDA 受体脑炎

Led 3 of the 264 English-language PubMed papers on anti-NMDA receptor encephalitis with an author in mainland China, 2021–2025: 1.1%.

Papers led
3
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 1120212022: 0020222023: 0020232024: 1120242025: 112025

12 hospitals in Guangzhou for anti-NMDA receptor encephalitis126 hospitals in China for anti-NMDA receptor encephalitis

No open trial on anti-NMDA receptor encephalitis lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersNeurology

Run the PubMed searchClinicalTrials.gov

Other diseases

Idiopathic pulmonary fibrosis

特发性肺纤维化

Led 1 of the 989 English-language PubMed papers on idiopathic pulmonary fibrosis with an author in mainland China, 2021–2025: 0.1%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 1120232024: 0020242025: 002025

20 hospitals in Guangzhou for idiopathic pulmonary fibrosis333 hospitals in China for idiopathic pulmonary fibrosis

No open trial on idiopathic pulmonary fibrosis lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersPediatrics

Run the PubMed searchClinicalTrials.gov

Other diseases

Amyotrophic lateral sclerosis

肌萎缩侧索硬化症

Led no English-language PubMed papers on amyotrophic lateral sclerosis in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

13 hospitals in Guangzhou for amyotrophic lateral sclerosis194 hospitals in China for amyotrophic lateral sclerosis

No open trial on amyotrophic lateral sclerosis lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Run the PubMed searchClinicalTrials.gov

Other diseases

Pompe disease

庞贝病

Led 1 of the 30 English-language PubMed papers on Pompe disease with an author in mainland China, 2021–2025: 3.3%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 1120222023: 0020232024: 0020242025: 002025

2 hospitals in Guangzhou for Pompe disease30 hospitals in China for Pompe disease

No open trial on Pompe disease lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Papers it led1
  1. Retrospective analysis of prenatal ultrasound of children with Pompe disease.2022Taiwanese journal of obstetrics & gynecology
Chinese-language papers (not in the count)1
  1. [GAA gene variants and genotype-phenotype correlations in patients with glycogen storage disease type Ⅱ].2021Zhonghua er ke za zhi = Chinese journal of pediatrics
Earlier papers (2016–2020)1
  1. Clinical and GAA gene mutation analysis in 21 Chinese patients with classic infantile pompe disease.2020European journal of medical genetics

Run the PubMed searchClinicalTrials.gov

Other diseases

Duchenne muscular dystrophy

杜氏肌营养不良

Led 2 of the 213 English-language PubMed papers on Duchenne muscular dystrophy with an author in mainland China, 2021–2025: 0.9%.

Papers led
2
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 2220222023: 0020232024: 0020242025: 002025

7 hospitals in Guangzhou for Duchenne muscular dystrophy116 hospitals in China for Duchenne muscular dystrophy

No open trial on Duchenne muscular dystrophy lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Run the PubMed searchClinicalTrials.gov

Other diseases

Alport syndrome

Alport 综合征

Led 2 of the 58 English-language PubMed papers on Alport syndrome with an author in mainland China, 2021–2025: 3.5%.

Papers led
2
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 1120212022: 0020222023: 0020232024: 0020242025: 112025

5 hospitals in Guangzhou for Alport syndrome60 hospitals in China for Alport syndrome

No open trial on Alport syndrome lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersNephrology

Run the PubMed searchClinicalTrials.gov

Other diseases

IgA nephropathy

IgA 肾病

Led no English-language PubMed papers on IgA nephropathy in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

20 hospitals in Guangzhou for IgA nephropathy346 hospitals in China for IgA nephropathy

No open trial on IgA nephropathy lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Run the PubMed searchClinicalTrials.gov

Other diseases

Gaucher disease

戈谢病

Led 1 of the 30 English-language PubMed papers on Gaucher disease with an author in mainland China, 2021–2025: 3.3%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 1120212022: 0020222023: 0020232024: 0020242025: 002025

4 hospitals in Guangzhou for Gaucher disease41 hospitals in China for Gaucher disease

No open trial on Gaucher disease lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Run the PubMed searchClinicalTrials.gov

Other diseases

Osteogenesis imperfecta

成骨不全症

Led 1 of the 99 English-language PubMed papers on osteogenesis imperfecta with an author in mainland China, 2021–2025: 1.0%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 0020242025: 112025

2 hospitals in Guangzhou for osteogenesis imperfecta59 hospitals in China for osteogenesis imperfecta

No open trial on osteogenesis imperfecta lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersPediatrics

Run the PubMed searchClinicalTrials.gov

Other diseases

Primary sclerosing cholangitis

原发性硬化性胆管炎

Led no English-language PubMed papers on primary sclerosing cholangitis in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

8 hospitals in Guangzhou for primary sclerosing cholangitis90 hospitals in China for primary sclerosing cholangitis

No open trial on primary sclerosing cholangitis lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Earlier papers (2016–2020)1
  1. Autoimmune liver disease-related autoantibodies in patients with biliary atresia.2018World journal of gastroenterology

Run the PubMed searchClinicalTrials.gov

Other diseases

Congenital diaphragmatic hernia

先天性膈疝

Led 11 of the 60 English-language PubMed papers on congenital diaphragmatic hernia with an author in mainland China, 2021–2025: 18.3%.

Papers led
11
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 1120222023: 2220232024: 5520242025: 332025

4 hospitals in Guangzhou for congenital diaphragmatic hernia46 hospitals in China for congenital diaphragmatic hernia

No open trial on congenital diaphragmatic hernia lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersRadiology / nuclear medicinePediatrics
Papers it led11
  1. Genetic burden and multidimensional predictors in prenatal diagnosis of fetal congenital diaphragmatic hernia.2025Human genetics
  2. Predictive Value of Esophageal Deviation Index for Clinical Outcomes of Patients With Left-Sided Congenital Diaphragmatic Hernia.2025Journal of pediatric surgery
  3. The timing of surgery for congenital diaphragmatic hernia in infants receiving extracorporeal membrane oxygenation: a meta-analysis.2025Pediatric surgery international
  4. The Timing of Surgery for Congenital Diaphragmatic Hernia in Infants, on or after Weaning from Extracorporeal Membrane Oxygenation: A Meta-Analysis.2024European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie
  5. Prenatal MRI assessment of mediastinal shift angle as a feasible and effective risk stratification tool in isolated right-sided congenital diaphragmatic hernia.2024European radiology
  6. Relative Mediastinal Displacement Index (RMDI): A Prenatal MRI Indicator of Adverse Events in Fetuses With Isolated Left Congenital Diaphragmatic Hernia.2024Journal of magnetic resonance imaging : JMRI
  7. Extracorporeal membrane oxygenation for congenital diaphragmatic hernia: how to begin?2024Minerva pediatrics
  8. Mechanical ventilation in special populations.2024Seminars in perinatology
  9. First-trimester prenatal diagnosis of Coffin-Siris syndrome-related congenital diaphragmatic hernia: The role of exome sequencing in determining genetic etiology.2023Congenital anomalies
  10. Mediastinal shift angle (MSA) measurement with MRI: a simple and effective tool for prenatal risk stratification in fetuses with congenital diaphragmatic hernia.2023European radiology
  11. Prenatal diagnosis of Coffin-Siris syndrome: What are the fetal features?2022Prenatal diagnosis
Earlier papers (2016–2020)4
  1. Simple and safe thoracoscopic repair of neonatal congenital diaphragmatic hernia by a new modified knot-tying technique.2019Hernia : the journal of hernias and abdominal wall surgery
  2. Standardized Indications to Assist in the Safe Thoracoscopic Repair of Congenital Diaphragmatic Hernia in Neonates.2016Journal of laparoendoscopic & advanced surgical techniques. Part A
  3. Decreased expression of miR-33 in fetal lungs of nitrofen-induced congenital diaphragmatic hernia rat model.2016Journal of pediatric surgery
  4. An unusual cause of shortness of breath in a young boy.2016Thorax

Run the PubMed searchClinicalTrials.gov

Other diseases

Hirschsprung disease

先天性巨结肠

Led 7 of the 161 English-language PubMed papers on Hirschsprung disease with an author in mainland China, 2021–2025: 4.3%.

Papers led
7
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 3320212022: 0020222023: 1120232024: 1120242025: 222025

8 hospitals in Guangzhou for Hirschsprung disease82 hospitals in China for Hirschsprung disease

No open trial on Hirschsprung disease lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersPediatrics
Papers it led7
  1. Refining the Sox10Dom/+ mouse model: A new breeding strategy with relevance to Hirschsprung disease genetics.2025Animal models and experimental medicine
  2. Suppression of SRC protein kinase activity alleviates the severity of aganglionosis by impairing CAV1/FLNA expression.2025Science progress
  3. Virus-Triggered Autoimmunity Was Associated With Hirschsprung's Disease Through Activation of Innate Immunity.2024Journal of immunology research
  4. Establishment and identification of an animal model of Hirschsprung disease in suckling mice.2023Pediatric research
  5. Correlation analysis of IL-11 polymorphisms and Hirschsprung disease subtype susceptibility in Southern Chinese Children.2021BMC medical genomics
  6. Associations of CYP2B6 genetic polymorphisms with Hirschsprung's disease in a southern Chinese population.2021Journal of clinical laboratory analysis
  7. Associations between common genetic variants in microRNAs and Hirschsprung disease susceptibility in Southern Chinese children.2021The journal of gene medicine
Earlier papers (2016–2020)14
  1. Long-term outcomes and quality of life of patients with Hirschsprung disease: a systematic review and meta-analysis.2020BMC gastroenterology
  2. Significant Association of rs2147555 Genetic Polymorphism in the EDNRB Gene with Hirschsprung Disease in Southern Chinese Children.2020BioMed research international
  3. miR-618 rs2682818 C>A polymorphism decreases Hirschsprung disease risk in Chinese children.2020Bioscience reports
  4. Parental Self-efficacy and Health-related Outcomes Among Children with Hirschsprung Disease: A Cross-sectional Study.2020Journal of pediatric nursing
  5. Association between miR-492 rs2289030 G>C and susceptibility to Hirschsprung disease in southern Chinese children.2020The Journal of international medical research
  6. Pleiotropic effect of common PHOX2B variants in Hirschsprung disease and neuroblastoma.2019Aging
  7. Associations of SLC6A20 genetic polymorphisms with Hirschsprung's disease in a Southern Chinese population.2019Bioscience reports
  8. Parental self-efficacy in managing the home care of children with Hirschsprung's disease or anorectal malformation: Development and validation of a new measure.2019Journal of psychosomatic research
  9. Association of VAMP5 and MCC genetic polymorphisms with increased risk of Hirschsprung disease susceptibility in Southern Chinese children.2018Aging
  10. Association between DSCAM polymorphisms and non-syndromic Hirschsprung disease in Chinese population.2018BMC medical genetics
  11. Association of NRG1 and AUTS2 genetic polymorphisms with Hirschsprung disease in a South Chinese population.2018Journal of cellular and molecular medicine
  12. Gene expression profiling coupled with Connectivity Map database mining reveals potential therapeutic drugs for Hirschsprung disease.2018Journal of pediatric surgery
  13. Establishment of an induced pluripotent stem cell model of Hirschsrpung disease, a congenital condition of the enteric nervous system, from a patient carrying a novel RET mutation.2018Neuroreport
  14. Large-scale replication study identified multiple independent SNPs in RET synergistically associated with Hirschsprung disease in Southern Chinese population.2017Aging

Run the PubMed searchClinicalTrials.gov

Getting in touch

Name card to show staff or a driver

广州市妇女儿童医疗中心

Guangzhou Women and Children's Medical Center

广州

Large hospitals often have several campuses. Confirm the campus with the hospital before travelling.

Inquiry letter in English and Chinese

Fill in the brackets, then send it through the contact options on the hospital's international office or official website. Nothing typed here leaves this device.

Records hospitals usually ask for

  • A recent summary or letter from the treating doctor
  • Pathology report
  • Scans (CT, MRI, PET) with their reports, and the images if possible
  • Treatments so far, with dates
  • Current medicines

What to do next

Talk with the treating doctorThis page can be shared with the treating doctor to discuss whether this team's work is relevant.
Check the team is still therePapers lag by months and doctors move. Look for the department on the hospital's own website.
Contact the hospital directlyUse the hospital's own contacts. Hospitals never pay us, and each hospital decides which patients it accepts.

Where these numbers come from

Papers

English-language PubMed papers whose first or last author lists this hospital as their first affiliation, 2021–2025. Definitions

Trials

ClinicalTrials.gov records naming this hospital as lead sponsor or site, as of 8 Nov 2026.

Identifiers and other names

ROR
Affiliated Guangzhou Women and Children's Hospital; Affiliated Guangzhou Women and Children's Medical Center; Guangzhou Women and Children's Medical Center Liuzhou Hospital; Guangzhou Women and Children's Medical Centre; Guangzhou Women and Children Medical Center; Guangzhou Women and Children's Hospital; Liuzhou Hospital of Guangzhou Women and Children's Medical Center

Suggest a correctionDownload the data